Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2020 - Improved Regional Healthcare Access to Drive Uptake of High-Cost Targeted Therapies

The Colorectal Cancer (CRC) therapeutics market in the four Asia-Pacific (APAC) countries of India, Australia, China and Japan was worth $1.9 billion in 2013 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 6.5% to $2.9 billion by 2020. Japan had the largest market in 2013, with a value of $1.2 billion, or a 65% share of the combined market of the four countries. Asia-Pacific Colorectal Cancer Therapeutics Market is expected to reach $2.9 Billion by 2020.